Recognition of virally infected cells by CD8؉ T cells requires differentiation between self and nonself peptide-class I major histocompatibility complexes (pMHC).
Clonotypic T cell receptors (TcR)1 recognize foreign or unnatural peptides bound to self class I MHC on the surface of antigen-presenting cells. These peptides are typically derived from proteins that are synthesized within the cell and are subsequently degraded by the proteasome. Thus, the peptides presented on the surface of a cell signal the peptidic contents or the "state" of the cell. When cytotoxic T cells recognize class I MHC-peptide complexes (pMHC) as nonnative or foreign, the cells bearing these pMHC are lysed (1). In an unexpected manner, many host T cells are also activated by the presence of foreign pMHC, and this is a major factor in graft rejection of transplanted tissues. Thus, the mechanism of peptide-specific allo-or xenoreactivity is of great interest to transplant physicians.The interaction between a TcR and class I MHC is not an "all or nothing" event. Altered peptide ligands (APLs) that only differ slightly from the original peptide lead to a continuum of different effects when presented to T cells (2, 3). Based upon the outcome of T cell activation, APLs may be defined as agonists or super agonists, which trigger similar or improved T cell responses compared with the original peptide ligand. APLs may also be null peptides that completely fail to stimulate any response either because of a failure to produce a productive signal upon engagement of the TcR or a failure to interact with the TcR at all. Furthermore, APLs may be antagonists. These APLs inhibit the ability of CTL to kill cells bearing the natural agonist peptide.The critical physical constants between pMHC and TcR that control the triggering of T cell activation are unknown. Early experiments using live T cells and antigen-presenting cells equated T cell activity to affinity of TcR for pMHC (2). However, a number of surface plasmon resonance experiments with soluble forms of pMHC and TcR indicate that the differences in the activity of agonist, antagonist, and null pMHC complexes are primarily due to variations in the off rates, or half-life, of the interaction (4 -7). Finally, some researchers have found that neither affinity nor kinetics correlate with the differences in T cell outcome (8). Although surface plasmon resonance experiments are valuable because they allow us to determine the kinetics and thermodynamics of the interaction between pMHC and TcR, these measurements fail to account for the involvement of co-receptors and accessory molecules on the cell surface that are also critical in T cell and antigen-presenting cell interactions, particularly when the affinity of the TcR to pMHC complex is low (9 -12). In addition, other physical interactions may be important for T cell activation including TcR dimerization or clustering (7, 13-15), although there is no evidence of physiological dimerization in any of the crystal structures determined to date (16 -22).In ...